Vitamin K2 sensitizes the efficacy of venetoclax in acute myeloid leukemia by targeting the NOXA-MCL-1 pathway. Tauchi T, Moriya S, Okabe S, Kazama H, et al. PLoS One 2024;19:e0307662.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tauchi T, Moriya S, Okabe S, Kazama H, et al. Vitamin K2 sensitizes the efficacy of venetoclax in acute myeloid leukemia by targeting the NOXA-MCL-1 pathway. PLoS One 2024;19:e0307662.
PMID: 39052583